IONQ

IONQ

$37.05

-1.20%
Sep 15, 2026
Bobby Quantitative Model
IonQ, Inc. is a quantum computing company that sells access to trapped-ion quantum computers of various qubit capacities, primarily through a quantum-computing-as-a-service (QCaaS) model delivered via major cloud platforms and its own cloud service, while also generating revenue from consulting engagements and contracts tied to the design, development, and construction of specialized quantum computing systems. As one of the few pure-play, publicly listed quantum hardware companies, IonQ positions itself as a potential platform leader in an industry still in its commercial infancy, competing against far larger incumbents such as IBM, Google, and emerging startups. The current investor narrative is dominated by the tension between explosive top-line growth — revenue has scaled from roughly $7.6 million in Q1 2025 to $64.7 million in Q1 2026 — and persistent unprofitability, with operating losses still running in the hundreds of millions of dollars annually. Recent news flow has focused on Washington's push toward direct government equity stakes in domestic quantum leaders, which could provide a sovereign-backed capital runway, alongside intense debate over whether IonQ can convert technical leadership into durable recurring revenue before its cash burn forces dilutive financing; the stock's roughly 22% one-year decline and 40%-plus drawdown from its all-time high frame this as a high-risk, high-reward commercialization story.

People also watch

Dell Technologies

Dell Technologies

DELL

Analysis
Arista Networks

Arista Networks

ANET

Analysis
Sandisk Corporation Common Stock

Sandisk Corporation Common Stock

SNDK

Analysis
Western Digital

Western Digital

WDC

Analysis
Hewlett Packard Enterprise

Hewlett Packard Enterprise

HPE

Analysis

BobbyInvestment Opinion: Should I buy IONQ Today?

The synthesized recommendation is Hold with a speculative bias. The core thesis is that IonQ offers genuine option value as a pure-play quantum computing leader with 755% year-over-year revenue growth and a fortress balance sheet, but the 96.75x P/S multiple and -$424.8 million trailing free cash flow mean investors are paying a steep price for a commercialization story that has not yet proven durable. The analyst consensus of 'strong_buy' with an average target of $69.25 (88.4% upside) anchors the bullish case, but the gap between that consensus and the stock's 21.9% one-year decline suggests targets may be anchored to outdated price levels.\n\nSupporting evidence for a constructive stance includes: (1) revenue scaling from $7.57 million in Q1 2025 to $64.67 million in Q1 2026, a 755% increase; (2) a current ratio of 15.50 and debt-to-equity of 0.0079, providing a multi-year runway; (3) P/B compression from 23.72x in Q4 2024 to 3.31x today, reflecting massive equity issuance that has ballooned book value; and (4) analyst revenue estimates averaging $1.95 billion, implying the market expects dramatic reacceleration. However, gross margin of 23.84% in Q1 2026 is well below the 56.48% in Q4 2025, and the negative operating margin of -4.87% means the premium is entirely narrative-driven.\n\nThe biggest risks that could invalidate the thesis are: (1) continued gross margin erosion below 20%, which would undermine the software-like margin narrative; (2) sequential revenue growth failing to reaccelerate above 10% QoQ, which would make the 96.75x P/S multiple unsustainable; and (3) further dilutive equity issuance that pressures the share price. This Hold would upgrade to Buy if gross margins stabilize above 40% and sequential revenue growth reaccelerates above 15% QoQ, or downgrade to Sell if revenue growth decelerates below 5% QoQ or if cash burn exceeds $200 million in a single quarter. Relative to its own history, the stock is at the low end of its P/S band (96.75x vs. 667.29x in Q1 2025), but relative to the hardware sector's 1-5x sales, it remains massively overvalued — the verdict is that the stock is fairly valued only if you believe the multi-year quantum opportunity justifies the premium.

Sign up to view all

IONQ 12-Month Price Forecast

IonQ presents a classic high-risk, high-reward quantum computing investment where the bull and bear cases are both credible. The 755% year-over-year revenue growth and fortress balance sheet (current ratio 15.50, debt-to-equity 0.0079) support the bull case, while the 96.75x P/S multiple, -$424.8 million trailing free cash flow, and gross margin collapse to 23.84% anchor the bear case. The analyst consensus of 'strong_buy' with an $69.25 average target suggests the sell-off may have overshot, but the absence of fresh upgrades during a 36% three-month decline indicates analysts are waiting for commercial proof. I would upgrade to bullish if gross margins stabilize above 40% and sequential revenue growth reaccelerates above 15% QoQ, and downgrade to bearish if cash burn exceeds $200 million in a single quarter or if the stock breaks below its 52-week low of $25.89 on high volume.

Historical Price
Current Price $37.05
Average Target $59.13
High Target $100.00
Low Target $25.89

Wall Street consensus

Most Wall Street analysts maintain a constructive view on IONQ's 12-month outlook, with a consensus price target around $69.25 and implied upside of +86.9% versus the current price.

Average Target

$69.25

0 analysts

Implied Upside

+86.9%

vs. current price

Analyst Count

covering this stock

Price Range

$49 - $100

Analyst target range

IonQ is covered by 12 analysts with a consensus recommendation of "strong_buy" (recommendation mean of 1.42 on a 1-5 scale where 1 is Strong Buy), and the average price target of $69.25 implies roughly 88.4% upside from the current price of $36.75. This is an unusually bullish consensus for a stock that has fallen 21.9% over the past year and 18.7% over the past month, suggesting that analysts are looking through near-term price weakness toward the multi-year quantum computing opportunity; the estimated average EPS of -$0.44 (range of -$0.65 to -$0.37) confirms that even the bulls expect losses to continue. The consensus leans decisively bullish, but the gap between the strong_buy rating and the stock's actual performance raises the question of whether analysts are anchored to outdated price levels or genuinely see a mispricing.

The target range is extraordinarily wide — from a low of $49.00 (still 33.3% above the current price) to a high of $100.00 (172.1% upside) — a $51 spread that signals very high uncertainty about the company's future. The high target of $100 likely assumes successful commercialization of next-generation quantum systems, government-backed contracts, and a re-rating toward a platform-level multiple, while the low target of $49 prices in continued execution but with more modest multiple expansion; notably, even the most bearish analyst target is above the current price, which is a rare configuration that could indicate the sell-off has overshot fundamentals or that targets are stale. The institutional ratings history shows a stable pattern of Buy ratings from Benchmark, Craig-Hallum, and Needham alongside Neutral/Equal Weight from Goldman Sachs and Morgan Stanley, with no recent downgrades visible in the data — but the absence of fresh upgrades during a 36% three-month decline suggests analysts are waiting for evidence of commercial traction before adjusting their views.

Drowning in data?

Find the real signal!

Bulls vs Bears: IONQ Investment Factors

The bear case currently has stronger near-term evidence: cash burn of -$424.8 million TTM, gross margin collapse to 23.84%, and a 36.47% three-month decline with 39.51 points of relative underperformance versus SPY. However, the bull case rests on a genuine 755% year-over-year revenue ramp, a fortress balance sheet with a 15.50 current ratio, and an analyst consensus target of $69.25 implying 88.4% upside. The single most important tension is whether IonQ can convert its lumpy, project-based revenue surge into durable, high-margin recurring QCaaS revenue before its cash burn forces dilutive financing. If gross margins stabilize above 40% and sequential revenue growth reaccelerates, the stock could re-rate sharply; if the Q1 2026 deceleration to +4.5% QoQ persists, the 96.75x P/S multiple faces severe compression risk.

Bullish

  • Explosive revenue growth from tiny base: Q1 2026 revenue reached $64.67 million, up roughly 755% from Q1 2025's $7.57 million, with sequential growth from $20.69M in Q2 2025 to $39.87M in Q3 2025 to $61.89M in Q4 2025. This trajectory demonstrates real commercial traction in system design and construction contracts, not just pilot programs.
  • Fortress balance sheet with minimal debt: Current ratio of 15.50 and debt-to-equity of just 0.0079 reflect a balance sheet funded almost entirely by equity, with $501.4 million in cash at Q1 2026. This provides a multi-year runway and eliminates near-term solvency risk, especially with Washington's push toward sovereign equity stakes in domestic quantum leaders.
  • Analyst consensus strongly bullish: 12 analysts rate IONQ a 'strong_buy' with a recommendation mean of 1.42, and the average target price of $69.25 implies 88.4% upside from $36.75. Even the lowest target of $49.00 sits 33.3% above the current price, a rare configuration suggesting the sell-off may have overshot fundamentals.
  • Valuation compressed versus own history: The P/S ratio has fallen from 667.29x in Q1 2025 to 96.75x today, and P/B has dropped from 23.72x in Q4 2024 to 3.31x, as revenue scaled and the stock declined. If the revenue trajectory holds, this multiple compression could represent a value opportunity rather than a warning.

Bearish

  • Deeply negative cash flow and rapid burn: Free cash flow was -$159.4 million in Q1 2026 and -$424.8 million on a trailing basis, with operating cash flow of -$151.0 million. The company burned roughly 30% of its $501.4 million cash balance in a single quarter, making continued dilution a near-certainty.
  • Gross margin collapse signals mix shift: Gross margin fell to 23.84% in Q1 2026 from 56.48% in Q4 2025 and 47.99% in Q3 2025, indicating revenue is shifting toward lower-margin system construction and away from high-margin QCaaS. This undermines the software-like margin thesis central to the long-term bull case.
  • Extreme valuation with no earnings in sight: P/S of 96.75x and EV/Sales of 48.62x are hundreds of percent above typical hardware sector multiples of 1-5x. Forward EPS of -$0.44 confirms analysts expect no profitability within the forecast horizon, leaving the valuation entirely narrative-driven.
  • Severe underperformance and technical weakness: IONQ has underperformed SPY by 39.51 percentage points over three months and 17.63 points over one month, with the stock down 36.47% in three months. At $36.75, it sits just 18.7% above its 52-week low of $25.89 and 56.6% below its 52-week high.

IONQ Technical Analysis

IonQ is in a sustained downtrend punctuated by violent counter-trend rallies, with the current price of $36.75 sitting just 18.7% above its 52-week low of $25.89 and a staggering 56.6% below its 52-week high of $84.64 — placing it at roughly 18.7% of its 52-week range, deep in the lower quartile. The 1-year price change of -21.89% and year-to-date decline of -21.42% confirm that the longer-term trend remains negative despite a strong six-month bounce of +11.43%, which suggests the stock is in a recovery attempt within a broader bear phase rather than a clean uptrend. Trading this close to the 52-week low signals that sellers remain in control and that the burden of proof is on the bulls to defend the $25.89-$30 zone; a failure there would open the door to new lows, while the depressed positioning also means any positive catalyst could produce outsized upside given the compressed base.

Short-term momentum has deteriorated sharply and is diverging bearishly from the six-month trend: the stock is down 18.69% over the past month and 36.47% over the past three months, even as the six-month figure remains positive at +11.43%, indicating that the spring rally has fully rolled over. This divergence — a positive 6-month return colliding with deeply negative 1-month and 3-month returns — is characteristic of a failed breakout and subsequent mean reversion, and the relative strength figures reinforce the severity: IonQ has underperformed SPY by 17.63 percentage points over one month and 39.51 points over three months, versus SPY's -1.06% and +3.04% respective moves. With no RSI provided, the magnitude of the decline (nearly 19% in a month) suggests the stock is approaching oversold territory, but the absence of a volume-confirmed capitulation and the elevated short ratio of 2.03 days-to-cover imply that bearish positioning is not yet extreme enough to force a squeeze.

Key technical levels are clearly defined: support rests at the 52-week low of $25.89, roughly 29.6% below the current $36.75, while resistance sits at the 52-week high of $84.64, an enormous 130.3% above the current price — a spread that underscores how much overhead supply exists. A decisive breakdown below $25.89 would signal that the market is pricing in fundamental deterioration or financing risk, whereas reclaiming the $45-$50 zone (the site of the July-August consolidation) would be the first step toward repairing the trend. The stock's beta of 3.295 is the critical risk-management input: IonQ is roughly 3.3 times as volatile as the S&P 500, meaning a 10% market drawdown could translate into a 33% move in IONQ, and the maximum drawdown of -67.61% over the observed period confirms that position sizing must be dramatically smaller than for a market-average equity.

Beta

3.29

3.29x market volatility

Max Drawdown

-67.6%

Largest decline past year

52-Week Range

$26-$85

Price range past year

Annual Return

-37.3%

Cumulative gain past year

PeriodIONQ ReturnS&P 500
1m-19.9%-2.4%
3m-32.3%+2.2%
6m+16.1%+14.8%
1y-37.3%+14.6%
ytd-20.8%+11.1%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

IONQ Fundamental Analysis

IonQ's revenue trajectory is genuinely explosive but from a tiny base: Q1 2026 revenue reached $64.67 million, up 7.55% year-over-year from the prior-year quarter, and up roughly 755% from Q1 2025's $7.57 million, reflecting a step-change driven by system-design and construction contracts rather than pure QCaaS. The multi-quarter progression — $20.69 million in Q2 2025, $39.87 million in Q3 2025, $61.89 million in Q4 2025, and $64.67 million in Q1 2026 — shows sequential growth that is decelerating sharply (from +93% QoQ in Q3 to +55% in Q4 to just +4.5% in Q1 2026), which raises the question of whether the lumpy, project-based revenue is sustainable or merely a one-time contract surge. Analyst estimates for average revenue of $1.95 billion (with a range of $1.71 billion to $2.68 billion) imply the market expects a dramatic reacceleration, and the investment case hinges entirely on whether that forecast is achievable.

Profitability remains deeply negative despite optically strong headline numbers: Q1 2026 reported net income of $805.36 million and diluted EPS of $2.07, but this is entirely an artifact of a $1.07 billion non-operating gain (totalOtherIncomeExpensesNet of $1,069.7 million), as operating income was actually -$271.5 million. Gross margin in Q1 2026 was just 23.84%, down sharply from 56.48% in Q4 2025 and 47.99% in Q3 2025, indicating that the revenue mix has shifted toward lower-margin system construction and away from high-margin QCaaS — a concerning trend for a company whose long-term thesis depends on software-like margins. The company's net margin of -3.93% and operating margin of -4.87% (on a trailing basis) mask the underlying cash economics, and with R&D running at $125.7 million in Q1 2026 alone, IonQ must scale revenue dramatically before operating leverage can turn positive.

On the balance sheet, IonQ is exceptionally liquid but structurally cash-consuming: the current ratio of 15.50 and debt-to-equity of just 0.0079 reflect a fortress balance sheet funded by equity issuance, with $501.4 million in cash at the end of Q1 2026. However, free cash flow is deeply negative — -$159.4 million in Q1 2026 and -$424.8 million on a trailing basis — and operating cash flow was -$151.0 million in the quarter, meaning the company burned through roughly 30% of its cash balance in a single quarter. ROE of -13.43% and ROA of -14.47% confirm that capital is being consumed rather than compounded, and the reliance on equity issuance ($1.95 billion raised in Q4 2025 alone) means continued dilution is a near-certainty unless the cash burn reverses; the 2028 cash-test narrative in recent news flow is directly tied to this dynamic.

Quarterly Revenue

$64668000.0B

2026-03

Revenue YoY Growth

+754.7%

YoY Comparison

Gross Margin

23.8%

Latest Quarter

Free Cash Flow

$-424755000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Open an Account, get $2 TSLA now!

Valuation Analysis: Is IONQ Overvalued?

Because IonQ's trailing net income is negative (trailing EPS of -$0.04 and trailing PE of -24.65), the PE ratio is not meaningful, and the appropriate primary metric is the price-to-sales ratio: at 96.75x trailing sales, the stock is priced for extraordinary future growth. The forward PE of -28.14 and forward EPS estimate of -$0.44 confirm that analysts do not expect profitability within the forecast horizon, so the valuation must be underwritten on revenue and cash-flow potential rather than earnings; the EV/Sales multiple of 48.62x is somewhat lower than the P/S because of the large net cash position, but it remains an extreme multiple that discounts years of hypergrowth.

Relative to the broader Technology sector and the Computer Hardware industry, IonQ's 96.75x P/S represents a massive premium — typical hardware companies trade at 1-5x sales, and even high-growth software companies rarely exceed 20-30x — implying a premium of several hundred percent to sector norms. This premium is only justifiable if IonQ's growth rate (which has been triple-digit on a year-over-year basis) and its option value as a quantum platform leader are sustained; the 40.40% gross margin is actually below what one would expect for a company commanding such a multiple, and the negative operating margin of -4.87% means the premium is entirely narrative-driven. The PEG ratio of -1.48 is not meaningful given negative earnings, but the price-to-book of 3.31x is more grounded and suggests the market values the company at roughly 3.3x its equity book value.

Historically, IonQ's valuation has been extraordinarily volatile: the P/S ratio was 159.97x in Q1 2026, 250.66x in Q4 2025, 454.35x in Q3 2025, and 667.29x in Q1 2025, meaning the current 96.75x is actually near the low end of its own historical band — a function of both the revenue ramp and the stock's decline. The P/B ratio tells a similar story, falling from 23.72x in Q4 2024 to 3.31x today, reflecting massive equity issuance that has ballooned book value while the share price fell. This compression could be read as a value opportunity if the revenue trajectory holds, but it could equally signal that the market is repricing the company from a speculative story stock toward a more sober assessment of its cash burn and dilution risk.

PE

-24.7x

Latest Quarter

vs. Historical

N/A

5-Year PE Range 17x~59x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

-24.4x

Enterprise Value Multiple

Investment Risk Disclosure

IonQ's financial risk profile is dominated by a cash burn that is structurally incompatible with its current revenue base. Trailing free cash flow stands at -$424.8 million against Q1 2026 revenue of just $64.67 million, and the company consumed roughly 30% of its $501.4 million cash balance in a single quarter. Gross margin collapsed to 23.84% in Q1 2026 from 56.48% in Q4 2025, indicating a mix shift toward lower-margin system construction, while R&D alone ran at $125.7 million in the quarter. Although debt-to-equity of 0.0079 and a current ratio of 15.50 eliminate near-term solvency risk, the reliance on equity issuance — $1.95 billion raised in Q4 2025 alone — means continued dilution is a near-certainty unless the burn reverses.\n\nMarket and competitive risks are amplified by IonQ's extreme valuation and volatility. At 96.75x trailing sales and 48.62x EV/Sales, the stock trades at a premium of several hundred percent to the Computer Hardware industry's typical 1-5x multiple, leaving it highly vulnerable to multiple compression if growth disappoints. Beta of 3.295 means the stock is roughly 3.3 times as volatile as the S&P 500, so a 10% market drawdown could translate into a 33% move in IONQ. Competitive threats from IBM, Google, and well-funded startups are intensifying, and recent news flow highlights a 2028 cash test for quantum companies, meaning capital access — not just technology — will determine sector winners. The absence of fresh analyst upgrades during a 36% three-month decline suggests the market is waiting for commercial proof before re-rating the stock.\n\nThe worst-case scenario would combine a failure to reaccelerate sequential revenue growth (Q1 2026 grew just 4.5% QoQ), continued gross margin erosion below 20%, and a broader risk-off rotation out of speculative technology names. In that chain of events, the stock would likely retest its 52-week low of $25.89, representing a 29.6% decline from the current $36.75, and a break below that level would open the door to new lows given the maximum drawdown of -67.61% observed over the period. Even the most bearish analyst target of $49.00 is above the current price, but if targets are stale and get revised downward following another weak quarter, the downside could extend toward the $20-$25 range, implying a loss of 32% to 46% from current levels. Position sizing must reflect this asymmetry, as the stock's 3.295 beta means drawdowns will be far more severe than the broader market.

FAQ

The most severe risk is financial: free cash flow of -$424.8 million TTM and a cash burn that consumed roughly 30% of the $501.4 million cash balance in Q1 2026 alone, making dilutive equity issuance a near-certainty. Second is valuation risk: at 96.75x trailing sales, the stock is priced for perfection, and any growth disappointment could trigger a sharp multiple compression. Third is competitive risk: IBM, Google, and well-funded startups are investing heavily in quantum computing, and IonQ's technical leadership is not guaranteed to translate into commercial dominance. Fourth is macro and volatility risk: beta of 3.295 means a 10% market drawdown could translate into a 33% move in IONQ, and the maximum drawdown of -67.61% shows the severity of potential losses. Ranked by severity, the cash burn and dilution risk is most immediate, followed by valuation compression, competitive disruption, and macro sensitivity.

The 12-month forecast has three scenarios: a bull case with 25% probability targeting $84.64-$100.00, a base case with 50% probability targeting $49.00-$69.25, and a bear case with 25% probability targeting $25.89-$49.00. The base case is most likely, assuming revenue grows toward the analyst average of $1.95 billion, gross margins stabilize in the 30-40% range, and cash burn moderates without a major dilutive event. The key assumption behind the base case is that IonQ successfully converts its system-design contracts into recurring QCaaS revenue while managing its cash runway through 2028. The bull case requires gross margin recovery above 40% and a government-backed capital runway, while the bear case would be triggered by a Q2 or Q3 2026 earnings miss, gross margin falling below 20%, or a highly dilutive equity raise at depressed prices.

IONQ is overvalued on traditional metrics but fairly valued relative to its own historical band if you believe the growth trajectory. The P/S ratio of 96.75x is hundreds of percent above the Computer Hardware industry's typical 1-5x multiple, and the EV/Sales of 48.62x remains extreme even after accounting for the large net cash position. However, the current P/S is actually near the low end of IonQ's own historical range, having fallen from 667.29x in Q1 2025 and 250.66x in Q4 2025, as revenue scaled and the stock declined. The P/B ratio tells a similar story, falling from 23.72x in Q4 2024 to 3.31x today. The market is paying a premium that implies it expects IonQ to grow into its valuation, with analyst revenue estimates averaging $1.95 billion. If that forecast is achieved, the multiple would compress dramatically; if it is not, the stock faces severe multiple compression risk.

From a risk/reward perspective, IONQ is a speculative buy only for aggressive investors who can tolerate extreme volatility and a multi-year holding period. The stock trades at $36.75 with an analyst average target of $69.25, implying 88.4% upside, and even the lowest target of $49.00 is 33.3% above the current price. However, the downside risk is equally severe: the 52-week low of $25.89 represents a 29.6% decline, and the maximum drawdown of -67.61% shows how quickly the stock can collapse. The biggest downside risk is continued cash burn of -$424.8 million TTM forcing dilutive equity issuance, which would pressure the share price regardless of revenue growth. For most investors, the 96.75x P/S multiple and 3.295 beta make this unsuitable as a core holding, but for those with a high risk tolerance and a 3-5 year horizon, a small position could capture the quantum computing option value.

IONQ is suitable only for long-term investment with a minimum holding period of 3-5 years, and even then only for investors who can tolerate extreme volatility. The company is in the early commercialization stage of quantum computing, with revenue of $64.67 million in Q1 2026 against a market cap of $12.58 billion, and analysts do not expect profitability within the forecast horizon (forward EPS of -$0.44). The 3.295 beta and -67.61% maximum drawdown make short-term trading extremely risky, as a 10% market move can translate into a 33% swing in IONQ. The absence of a dividend (payout ratio of 0) means there is no income component to cushion returns. A concrete suggested minimum holding period is 3 years, by which time the 2028 cash test will have resolved and the company's ability to generate recurring QCaaS revenue at scale will be clearer. Short-term trading should be avoided unless using strict stop-losses given the 36.47% three-month decline.